Aerovate Therapeutics Income Statement

Financials in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	41,496,745	38,729,493	42,086,952	47,539,987	25,707,069	17,715,928	Upgrade
Revenue Growth (YoY)	1.50%	-7.98%	-11.47%	84.93%	45.11%	-18.37%	Upgrade
Cost of Revenue	37,627,990	35,229,082	37,622,034	43,299,082	23,421,775	15,674,632	Upgrade
Gross Profit	3,868,754	3,500,412	4,464,918	4,240,904	2,285,294	2,041,296	Upgrade
Selling, General & Admin	1,010,124	965,968	966,324	1,117,585	829,988	839,873	Upgrade
Other Operating Expenses	-15,146	-26,598	-41,033	-2,375	9,034	-7,106	Upgrade
Operating Expenses	994,978	939,369	925,291	1,115,210	839,022	832,767	Upgrade
Operating Income	2,873,777	2,561,042	3,539,627	3,125,695	1,446,272	1,208,529	Upgrade
Interest Expense	-83,814	-84,909	-68,489	-57,213	-57,069	-74,284	Upgrade
Interest & Investment Income	352,599	352,599	196,567	49,074	37,129	50,071	Upgrade
Earnings From Equity Investments	37,029	46,467	34,535	16,633	7,144	469	Upgrade
Currency Exchange Gain (Loss)	33,177	13,690	6,249	-45,972	4,562	-26,148	Upgrade
EBT Excluding Unusual Items	3,180,850	2,888,889	3,708,490	3,088,217	1,438,038	1,158,636	Upgrade
Gain (Loss) on Sale of Assets	5,243	3,733	14,658	7,059	7,523	84,339	Upgrade
Pretax Income	3,186,093	2,892,622	3,723,147	3,095,276	1,445,562	1,242,975	Upgrade
Income Tax Expense	542,130	493,155	644,678	616,217	310,560	280,978	Upgrade
Earnings From Continuing Operations	2,643,963	2,399,468	3,078,470	2,479,059	1,135,002	961,997	Upgrade
Net Income to Company	2,643,963	2,399,468	3,078,470	2,479,059	1,135,002	961,997	Upgrade
Minority Interest in Earnings	-241,748	-174,350	-298,120	-75,724	-23,388	-37,079	Upgrade
Net Income	2,402,216	2,225,118	2,780,350	2,403,335	1,111,614	924,918	Upgrade
Net Income to Common	2,402,216	2,225,118	2,780,350	2,403,335	1,111,614	924,918	Upgrade
Net Income Growth	-12.72%	-19.97%	15.69%	116.20%	20.18%	28.96%	Upgrade
Shares Outstanding (Basic)	-	19,738	19,737	19,737	19,737	19,803	Upgrade
Shares Outstanding (Diluted)	-	19,738	19,737	19,737	19,737	19,803	Upgrade
Shares Change (YoY)	-	0.01%	-	-	-0.33%	-0.44%	Upgrade
EPS (Basic)	-	112.73	140.87	121.77	56.32	46.71	Upgrade
EPS (Diluted)	-	112.73	140.87	121.77	56.32	46.71	Upgrade
EPS Growth	-	-19.98%	15.69%	116.20%	20.59%	29.54%	Upgrade
Free Cash Flow	1,172,520	159,237	2,853,380	2,338,662	2,702,799	725,956	Upgrade
Free Cash Flow Per Share	-	8.07	144.57	118.49	136.94	36.66	Upgrade
Dividend Per Share	-	-	125.000	75.000	29.000	25.000	Upgrade
Dividend Growth	-	-	66.67%	158.62%	16.00%	13.64%	Upgrade
Gross Margin	9.32%	9.04%	10.61%	8.92%	8.89%	11.52%	Upgrade
Operating Margin	6.93%	6.61%	8.41%	6.58%	5.63%	6.82%	Upgrade
Profit Margin	5.79%	5.75%	6.61%	5.05%	4.32%	5.22%	Upgrade
Free Cash Flow Margin	2.83%	0.41%	6.78%	4.92%	10.51%	4.10%	Upgrade
EBITDA	3,298,561	2,977,386	3,931,652	3,504,157	1,803,197	1,545,242	Upgrade
EBITDA Margin	7.95%	7.69%	9.34%	7.37%	7.01%	8.72%	Upgrade
D&A For EBITDA	424,785	416,343	392,025	378,462	356,925	336,713	Upgrade
EBIT	2,873,777	2,561,042	3,539,627	3,125,695	1,446,272	1,208,529	Upgrade
EBIT Margin	6.93%	6.61%	8.41%	6.58%	5.63%	6.82%	Upgrade
Effective Tax Rate	17.02%	17.05%	17.32%	19.91%	21.48%	22.61%	Upgrade
Revenue as Reported	41,496,745	38,729,493	42,086,952	47,539,987	-	-	Upgrade
Advertising Expenses	-	18,039	24,190	14,613	11,715	4,664	Upgrade

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.